Mark your calendar! The Option trial compares the safety and effectiveness of the WATCHMAN FLX device with oral anticoagulation for stroke prevention post-ablation. #LAAC #WatchmanFLX #BSCI
We are excited to announce that results from the OPTION Clinical Trial have been accepted as a Late-Breaking Science Session at the 2024 AHA Conference! This pivotal study compares the safety and effectiveness of the WATCHMAN FLX™ #LAAC device with oral anticoagulation for stroke prevention post-ablation. Learn more about OPTION here: https://bit.ly/4drSpmE